Goda K - Search Results

1

P-glycoprotein inhibition by membrane cholesterol modulation.

Fenyvesi F, Fenyvesi E, Szente L, Goda K, Bacsó Z, Bácskay I, Váradi J, Kiss T, Molnár E, Janáky T, Szabó G Jr, Vecsernyés M. Fenyvesi F, et al. Among authors: goda k. Eur J Pharm Sci. 2008 Aug 7;34(4-5):236-42. doi: 10.1016/j.ejps.2008.04.005. Epub 2008 Apr 29. Eur J Pharm Sci. 2008. PMID: 18539442

2

Reversal of multidrug resistance by valinomycin is overcome by CCCP.

Goda K, Krasznai Z, Gaspar R, Lankelma J, Westerhoff HV, Damjanovich S, Szabó G Jr. Goda K, et al. Biochem Biophys Res Commun. 1996 Feb 15;219(2):306-10. doi: 10.1006/bbrc.1996.0228. Biochem Biophys Res Commun. 1996. PMID: 8604982

3

Intracellular pH does not affect drug extrusion by P-glycoprotein.

Goda K, Balkay L, Márián T, Trón L, Aszalós A, Szabó G Jr. Goda K, et al. J Photochem Photobiol B. 1996 Jul;34(2-3):177-82. doi: 10.1016/1011-1344(95)07282-9. J Photochem Photobiol B. 1996. PMID: 8810535

4

Conformational heterogeneity of P-glycoprotein.

Goda K, Nagy H, Bene L, Balázs M, Arceci R, Mechetner E, Szabó G. Goda K, et al. Cancer Detect Prev. 2000;24(5):415-21. Cancer Detect Prev. 2000. PMID: 11129983

5

P-Glycoprotein conformational changes detected by antibody competition.

Nagy H, Goda K, Arceci R, Cianfriglia M, Mechetner E, Szabó G Jr. Nagy H, et al. Among authors: goda k. Eur J Biochem. 2001 Apr;268(8):2416-20. doi: 10.1046/j.1432-1327.2001.02122.x. Eur J Biochem. 2001. PMID: 11298761 Free article.

6

Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma.

Maródi L, Goda K, Palicz A, Szabó G. Maródi L, et al. Among authors: goda k. Clin Exp Immunol. 2001 Dec;126(3):456-60. doi: 10.1046/j.1365-2249.2001.01693.x. Clin Exp Immunol. 2001. PMID: 11737062 Free PMC article.

7

Effects of ATP depletion and phosphate analogues on P-glycoprotein conformation in live cells.

Goda K, Nagy H, Mechetner E, Cianfriglia M, Szabó G Jr. Goda K, et al. Eur J Biochem. 2002 Jun;269(11):2672-7. doi: 10.1046/j.1432-1033.2002.02929.x. Eur J Biochem. 2002. PMID: 12047375 Free article.

When the UIC2-shift was elicited by certain modulators (e.g. cyclosporin A or vinblastine, but not with verapamil or Tween 80), the subsequent binding of other monoclonal anti-Pgp Ig sharing epitopes with UIC2 (e.g. MM12.10) was abolished [Nagy, H., Goda, K., Arceci …

When the UIC2-shift was elicited by certain modulators (e.g. cyclosporin A or vinblastine, but not with verapamil or Tween 80), the subseque …

8

In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.

Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska L, Balkay L, Mikecz P, Trón L, Krasznai Z. Márián T, et al. Among authors: goda k. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1147-54. doi: 10.1007/s00259-003-1204-3. Epub 2003 Jun 27. Eur J Nucl Med Mol Imaging. 2003. PMID: 12830325

9

Non-random features of loop-size chromatin fragmentation.

Szilágyi I, Varga T, Székvölgyi L, Hegedüs E, Goda K, Kaczur V, Bacsó Z, Nakayama Y, Pósafi J, Pongor S, Szabó G Jr. Szilágyi I, et al. Among authors: goda k. J Cell Biochem. 2003 Aug 15;89(6):1193-205. doi: 10.1002/jcb.10591. J Cell Biochem. 2003. PMID: 12898517

10

Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.

Nagy H, Goda K, Fenyvesi F, Bacsó Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabó G Jr. Nagy H, et al. Among authors: goda k. Biochem Biophys Res Commun. 2004 Mar 19;315(4):942-9. doi: 10.1016/j.bbrc.2004.01.156. Biochem Biophys Res Commun. 2004. PMID: 14985103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters